Drugs / CG8123
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00089726 | Mar 2003 → Jan 2006 | non-small cell lung carcinoma | Cell Genesys | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CG8123 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00089726 ↗ |
| Action | Deplete | “This study will try to determine if vaccine given with or without this chemotherapy is effective in destroying lung cancer cells.” NCT00089726 ↗ |
| Modality | Vaccine | “GM-CSF Gene-Modified Autologous Tumor Vaccine (CG8123)” NCT00089726 ↗ |